Carcinoembryonic Antigen as a Vaccine Target

作者: Jeffrey Schlom , Kwong Y. Tsang , James W. Hodge , John W. Greiner

DOI: 10.1007/978-94-017-0963-7_5

关键词:

摘要: The human carcinoembryonic antigen (CEA) as a target for vaccine-mediated therapy of range cancers will be reviewed. first section provide an overview the CEA gene family and levels expression in neoplastic preneoplastic lesions, some normal fetal tissues. pros cons using animal models then discussed (a) defming optimal strategies inducing immune response antitumor to “self”-antigen such CEA, (b) prelude clinical studies. numerous studies that have now been carried out define immunogenicity humans reviewed; this also include on definition enhancer T-cell agonist epitope has shown enhance responses CEA. Finally, multiple can used further self-antigen including use vectors containing transgenes costimulatory molecules. potential implementation these vaccine trials discussed.

参考文章(90)
J Schlom, P Correale, S Zaremba, M Zhu, D Cole, C Lam, K Y Tsang, J M Hamilton, C A Nieroda, Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen Clinical Cancer Research. ,vol. 3, pp. 2439- 2449 ,(1997)
P Matzinger, Tolerance, danger, and the extended family. Annual Review of Immunology. ,vol. 12, pp. 991- 1045 ,(1994) , 10.1146/ANNUREV.IY.12.040194.005015
J E Coligan, M A Bednarek, K C Parker, Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. Journal of Immunology. ,vol. 152, pp. 163- 175 ,(1994)
Matthias G.O. Lorenz, Judith A. Kantor, Jeffrey Schlom, James W. Hodge, Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L). Human Gene Therapy. ,vol. 10, pp. 1095- 1103 ,(1999) , 10.1089/10430349950018094
Malik E. Juweid, Yehuda Vardi, Lawrence C. Swayne, Zhiliang Ying, David M. Goldenberg, Cunhui Zhang, Rae C. Vagg, Robert M. Sharkey, Jeffry A. Siegel, Thomas M. Behr, Robert M. Dunn, Phase I/II Clinical Radioimmunotherapy with an Iodine-131 -Labeled Anti-Carcinoembryonic Antigen Murine Monoclonal Antibody IgG The Journal of Nuclear Medicine. ,vol. 38, pp. 858- 870 ,(1997)
Malik Juweid, Lawrence C. Swayne, David M. Goldenberg, Thomas Herskovic, Debra Hanley, Robert Dunn, Robert M. Sharkey, Jeffry Siegel, Arnold D. Rubin, Thomas Behr, Michael Pereira, Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. The Journal of Nuclear Medicine. ,vol. 37, pp. 905- 911 ,(1996)
K Shimokata, T Hasegawa, I Nakashima, K Isobe, Quantitative analysis of antigen for the induction of tolerance in carcinoembryonic antigen transgenic mice. Immunology. ,vol. 77, pp. 577- 581 ,(1992)
S. Von Kleist, B. Halla, I. Migule, Possible function of CEA as cell-contact inhibitory molecule. Anticancer Research. ,vol. 15, pp. 1889- 1894 ,(1995)
L A Sumerel, D L Barlow, D T Curiel, R M Conry, F Loechel, S E Moore, J Pike, A F LoBuglio, A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Therapy. ,vol. 2, pp. 33- 38 ,(1995)